Price erosion in US generics
Sacubitril launch faces competitive pricing pressure; price erosion could impact US revenue growth in subsequent quarters.
high · management_commentaryAlkem Laboratories Limited — Q2 FY26
Alkem delivered a strong Q2 FY26 with revenue of ₹4,010 crore (+17.2% YoY), driven by robust growth across India (+12.4%), US (+28%), and non-US markets (+32.4%).
bullish
high
Financial stats pending filing verification
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
GST impact on margins
GST revision will reduce benefits from Sikkim facility, causing a ₹50-60 crore impact in H2, pressuring margins.
medium · management_commentaryUS CDMO ramp-up and breakeven timeline
CDMO plant opex of ₹50 cr/quarter with only ₹20 cr revenue initially; breakeven expected in 12-18 months, but delays could weigh on profitability.
medium · analyst_questionPenicillin G MIP uncertainty
Government may impose minimum import price on Penicillin G; management declined to comment, citing speculation, but it could increase costs.
low · analyst_question